Skip to main content

PharmaVOICE Recognizes Kantar Health’s Jade Cusick as one of 100 Most Inspiring Leaders in Life Sciences

Award recognizes leaders who impact the industry through innovation and positive actions

Kantar Health, a leader in research, data and consulting for the life sciences industry and recently acquired by the Cerner Corporation on April 1, 2021, announced today that Jade Cusick, Chief Commercial Officer, has been named one of 2021’s Most Inspiring Leaders in Life Sciences by PharmaVOICE.

Jade is recognized for his vision and commitment to people and meaningful relationships, both internally with colleagues and externally with clients. He has built his career on the dual tracks of building and developing client relationships, while also identifying and nurturing team members within the business, as the basis of a successful growth and business development strategy.

“Putting the client at the center of everything we do has been the guiding force behind Kantar Health’s strategy and Jade has been instrumental in the creation and execution of a new organizational design that matches this philosophy,” said Lynnette Cooke, Global CEO, Kantar Health. “In just a couple of years, Jade’s vision to deliver the best of Kantar Health to clients, regardless of geography, has resulted in significant growth. He is also passionate about a broad and diverse portfolio of clients and, under his leadership, our client base is now made up of nearly 50% small and medium life sciences companies.”

Mentoring the wider team is another key focus for Jade. He inspires individuals to be successful in their careers at Kantar Health and has created a global and collaborative business development team. Alongside others, Jade created the “First Chair” training program as an investment for client facing teams. This interactive, intensive training is often the highlight of employee training opportunities at Kantar Health. With a focus on understanding the client’s central question and encouraging collaboration and teamwork, the program has fundamentally enhanced the way Kantar Health teams with clients and is a key part of its growth story.

“I am honored by this recognition and humbled by the opportunity to work with the dedicated and outstanding team at Kantar Health that have played such a big part in getting us to where we are today,” said Jade Cusick, Chief Commercial Officer, Kantar Health. “I’ve been so fortunate to have Lynnette and a couple other brilliant mentors in my career that truly shaped who I’ve become as a leader, and so lucky to be surrounded by the incredible team we have at Kantar Health, and now Cerner. It’s been a fantastic trip so far and I’m looking forward to our next chapter under Cerner’s ownership!”

PharmaVOICE 100 Most Inspiring Leaders recognizes honorees for inspirational qualities as well as the ability to view industry trends as opportunities not obstacles; passion and conviction for the industry; ability to innovate and think outside of the box and develop breakthrough strategies, products and services; for pioneering new paths and lifting their company to new heights; for taking the time to mentor and guide the next generation of industry leaders; and for dedication to improving the lives of patients.

The full list of winners was recently announced in the July/August issue of PharmaVOICE.

About Kantar Health:

Kantar Health provides data, analytics and research to the life sciences industry. As real-world evidence and commercialization partners, Kantar Health enables clients to bring safe and effective treatment to patients around the world. The team has expertise across a myriad of therapy areas, including unique thought leadership in oncology and rare diseases. For more information on how to optimize commercial launch plans, demonstrate real-world effectiveness and safety, and build ongoing value substantiation to unlock your full potential, visit www.kantar.com/health

Contacts

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.